CLINICA 100 TOP 10: Abbott Labs
This article was originally published in Clinica
Abbott Labs has moved up one position from last year to No 8 in our Clinica 100 list*. It remains at No 4 in both the IVD and Cardiology lists. Abbott has not made any big M&A deals in 2014/2015, looking instead to build its cardiovascular business with promising technologies that gives it access to fast-growing emerging segments. In 2014, it moved into the electrophysiology space for the first time with the acquisition of ablation mapping specialist Topera Medical. It also secured the rights to buy at a later date Advanced Cardiac Therapeutics, which is sdeveloping an irrigated radiofrequency ablation catheter technology.